Zevra Therapeutics (ZVRA) Reports Q1 Loss, Tops Revenue Estimates

• click to rate

  Posted by Two Blokes Tue at 11:30 PM - Filed in Stock - 2 views
  
  Zevra Therapeutics (ZVRA) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.40 per share a year ago.